CAV 200 Pill: beige, capsule/oblong, 14mm
Generic Name: capivasertib
The pill with imprint CAV 200 (Beige, Capsule/Oblong, 14mm) has been identified as Truqap 200 mg and is used for Breast Cancer. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for CAV 200
Truqap
- Generic Name
- capivasertib
- Imprint
- CAV 200
- Strength
- 200 mg
- Color
- Beige
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-9501
See also:
More about Truqap (capivasertib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.